Belay Diagnostics
Biotechnology, 2450 Holcombe Boulevard, Chicago, Illinois, 77021, United States, 11-50 Employees
Phone Number: +18*********
Who is BELAY DIAGNOSTICS
Belay Diagnostics provides next-gen sequencing to detect aneuploidy and mutations with our cerebrospinal fluid testing platform. Improving diagnosis for brain and spinal cord cancers can ...
Read More
-
Headquarters: 2450 Holcombe Boulevard, Chicago, Illinois, 77021, United States
-
Date Founded: 2022
-
Employees: 11-50
-
Revenue: $50 Million to $100 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 8071
|
NAICS Code: 561110 |
Show More
Does something look wrong? Fix it. | View contact records from BELAY DIAGNOSTICS
Email
Phone
Similar Companies to Belay Diagnostics
Radyus Research
-
11-50
-
$ 1 Million to 5 Million
Talis Biomedical Corporation
-
51-200
-
$ 25 Million to 50 Million
Tempus AI
-
1001-5000
-
$ 100 Million to 250 Million
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Belay Diagnostics
Answer: Belay Diagnostics's headquarters are located at 2450 Holcombe Boulevard, Chicago, Illinois, 77021, United States
Answer: Belay Diagnostics's phone number is +18*********
Answer: Belay Diagnostics's official website is https://belaydiagnostics.com
Answer: Belay Diagnostics's revenue is $50 Million to $100 Million
Answer: Belay Diagnostics's SIC: 8071
Answer: Belay Diagnostics's NAICS: 561110
Answer: Belay Diagnostics has 11-50 employees
Answer: Belay Diagnostics is in Biotechnology
Answer: Belay Diagnostics top competitors include: Radyus Research , Talis Biomedical Corporation , Tempus AI
Answer: Belay Diagnostics contact info: Phone number: +18********* Website: https://belaydiagnostics.com
Answer: Belay Diagnostics provides next-gen sequencing to detect aneuploidy and mutations with our cerebrospinal fluid testing platform. Improving diagnosis for brain and spinal cord cancers can give people the best chance for a cure without the need for invasive biopsies. We see our technological advances in cerebrospinal fluid assays as offering clinicians alternative diagnostic tools for use in treatment decisions.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month